| Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia—TCD With Transfusions Changing to … RE Ware, BR Davis, WH Schultz, RC Brown, B Aygun, S Sarnaik, I Odame, ... The Lancet 387 (10019), 661-670, 2016 | 476 | 2016 |
| Erythrocyte NADPH oxidase activity modulated by Rac GTPases, PKC, and plasma cytokines contributes to oxidative stress in sickle cell disease A George, S Pushkaran, DG Konstantinidis, S Koochaki, P Malik, ... Blood, The Journal of the American Society of Hematology 121 (11), 2099-2107, 2013 | 204 | 2013 |
| Altered phosphorylation of cytoskeleton proteins in sickle red blood cells: the role of protein kinase C, Rac GTPases, and reactive oxygen species A George, S Pushkaran, L Li, X An, Y Zheng, N Mohandas, CH Joiner, ... Blood Cells, Molecules, and Diseases 45 (1), 41-45, 2010 | 89 | 2010 |
| Validation of a low-cost paper-based screening test for sickle cell anemia NZ Piety, X Yang, J Kanter, SM Vignes, A George, SS Shevkoplyas PLoS One 11 (1), e0144901, 2016 | 61 | 2016 |
| The homeobox gene Hex induces T-cell-derived lymphomas when overexpressed in hematopoietic precursor cells A George, HC Morse III, MJ Justice Oncogene 22 (43), 6764-6773, 2003 | 58 | 2003 |
| Losartan for the nephropathy of sickle cell anemia: A phase‐2, multicenter trial CT Quinn, SL Saraf, VR Gordeuk, CD Fitzhugh, SE Creary, P Bodas, ... American journal of hematology 92 (9), E520-E528, 2017 | 43 | 2017 |
| A paper-based test for screening newborns for sickle cell disease NZ Piety, A George, S Serrano, MR Lanzi, PR Patel, MP Noli, S Kahan, ... Scientific reports 7 (1), 45488, 2017 | 43 | 2017 |
| A rapid paper‐based test for quantifying sickle hemoglobin in blood samples from patients with sickle cell disease NZ Piety, X Yang, D Lezzar, A George, SS Shevkoplyas American journal of hematology 90 (6), 478-482, 2015 | 43 | 2015 |
| Randomized phase 2 trial of regadenoson for treatment of acute vaso-occlusive crises in sickle cell disease JJ Field, E Majerus, VR Gordeuk, M Gowhari, C Hoppe, MM Heeney, ... Blood advances 1 (20), 1645-1649, 2017 | 42 | 2017 |
| Double-blind, randomized, multicenter phase 2 study of SC411 in children with sickle cell disease (SCOT trial) AA Daak, CD Dampier, B Fuh, J Kanter, OA Alvarez, LV Black, ... Blood advances 2 (15), 1969-1979, 2018 | 33 | 2018 |
| Whole‐exome sequencing of sickle cell disease patients with hyperhemolysis syndrome suggests a role for rare variation in disease predisposition S Mwesigwa, JM Moulds, A Chen, J Flanagan, VA Sheehan, A George, ... Transfusion 58 (3), 726-735, 2018 | 21 | 2018 |
| The impact of the 2009 H1N1 influenza pandemic on pediatric patients with sickle cell disease A George, J Benton, J Pratt, MO Kim, KA Kalinyak, TA Kalfa, CH Joiner Pediatric blood & cancer 57 (4), 648-653, 2011 | 18 | 2011 |
| Substituting sodium hydrosulfite with sodium metabisulfite improves long-term stability of a distributable paper-based test kit for point-of-care screening for sickle cell anemia K Torabian, D Lezzar, NZ Piety, A George, SS Shevkoplyas Biosensors 7 (3), 39, 2017 | 14 | 2017 |
| Rac GTPases in erythroid biology DG Konstantinidis, A George, TA Kalfa Transfusion clinique et biologique 17 (3), 126-130, 2010 | 14 | 2010 |
| Benjamin Mizukawa, MD, Alex George, MD, PhD, Suvarnamala Pushkaran, MS, Lana Weckbach, PhD KA Kalinyak, JE Heubi, TA Kalfa Pediatr Blood Cancer 56, 840-842, 2010 | 14* | 2010 |
| Novel dose escalation to predict treatment with hydroxyurea (NDEPTH): a randomized controlled trial of a dose‐prediction equation to determine maximum tolerated dose of … A George, B Dinu, N Estrada, CG Minard, R Hurwitz, DH Mahoney, ... American Journal of Hematology 95 (9), E242-E244, 2020 | 5 | 2020 |
| Clinical effect of SC411 (Altemia TM) on children with sickle cell disease in the scot trial: A phase 2 randomized, double-blind, placebo-controlled, parallel-group, dose … A Daak, M Heeney, C Dampier, B Fuh, J Kanter, O Alvarez, V Black, ... PEDIATRIC BLOOD & CANCER 65, 2018 | 2 | 2018 |
| Safety and efficacy of dose‐escalation hydroxyurea therapy in very young children with sickle cell anemia: A retrospective cohort study A George, JN Tran Pediatric Blood & Cancer 67 (9), e28461, 2020 | | 2020 |
| EFFECTS OF SC411 (ALTEMIATM) ON BLOOD CELL MEMBRANE OMEGA-3 INDEX AND SELECT SICKLE CELL DISEASE BIOMARKERS IN THE SCOT TRIAL: A PHASE 2 RANDOMIZED, DOUBLE-BLIND, PLACEBO … A Daak, M Heeney, C Dampier, B Fuh, J Kanter, O Alvarez, V Black, ... PEDIATRIC BLOOD & CANCER 65, 2018 | | 2018 |
Theodosia KalfaCincinnati Children's HospitalVerified email at cchmc.org
